What antibiotics are recommended for acute bacterial tonsillitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotic Treatment for Acute Bacterial Tonsillitis

For acute bacterial tonsillitis caused by Group A Streptococcus (GAS), penicillin V or amoxicillin for 10 days are the first-line antibiotics, with penicillin V specifically recommended at 250 mg twice daily or 500 mg twice daily in adults. 1

First-Line Treatment (No Penicillin Allergy)

The IDSA guideline provides strong, high-quality evidence for the following regimens 1:

Oral Options:

  • Penicillin V:

    • Children: 250 mg 2-3 times daily
    • Adolescents/Adults: 250 mg 4 times daily OR 500 mg twice daily
    • Duration: 10 days
  • Amoxicillin:

    • 50 mg/kg once daily (max 1000 mg) OR 25 mg/kg twice daily (max 500 mg per dose)
    • Duration: 10 days

Intramuscular Option:

  • Benzathine penicillin G: Single dose (600,000 U if <27 kg; 1,200,000 U if ≥27 kg)

Recent evidence from Germany confirms penicillin V as first-line for tonsillopharyngitis 2, and a large retrospective study of 242,366 cases found that penicillin V treatment resulted in fewer additional physician visits compared to other antibiotics 3.

For Penicillin-Allergic Patients

The guideline stratifies alternatives based on allergy type 1:

If NOT immediate-type hypersensitivity:

  • Cephalexin: 20 mg/kg/dose twice daily (max 500 mg/dose) for 10 days (strong, high evidence)
  • Cefadroxil: 30 mg/kg once daily (max 1 g) for 10 days (strong, high evidence)

If immediate-type hypersensitivity or cephalosporin contraindicated:

  • Clindamycin: 7 mg/kg/dose 3 times daily (max 300 mg/dose) for 10 days (strong, moderate evidence)
  • Azithromycin: 12 mg/kg once daily (max 500 mg) for 5 days (strong, moderate evidence)
  • Clarithromycin: 7.5 mg/kg/dose twice daily (max 250 mg/dose) for 10 days (strong, moderate evidence)

Critical Caveats

Macrolide Resistance: The guideline explicitly warns that resistance of GAS to azithromycin and clarithromycin is well-known and varies geographically and temporally 1. Use these agents cautiously and consider local resistance patterns.

Avoid Cephalosporins in Immediate Hypersensitivity: First-generation cephalosporins should be avoided in patients with immediate-type penicillin allergy due to cross-reactivity risk 1.

Duration Matters: The 10-day duration for penicillin/amoxicillin is critical for preventing rheumatic fever and suppurative complications. While shorter courses have been studied, the standard remains 10 days for penicillin-based regimens 1.

When to Treat

Before prescribing antibiotics, confirm high probability of bacterial (GAS) infection using:

  • Centor or McIsaac scoring to assess likelihood 4, 5
  • Rapid antigen detection test (RADT) or throat culture if score ≥3 5

The primary goals of antibiotic treatment are preventing acute rheumatic fever, preventing suppurative complications (peritonsillar abscess, cervical lymphadenitis), improving symptoms, and reducing contagiousness 1.

What NOT to Do

  • Do not treat GAS carriers - they don't require antimicrobial therapy as they're unlikely to spread infection or develop complications 1
  • Do not routinely check post-treatment cultures or ASLO titers 5
  • Avoid fluoroquinolones, higher-generation cephalosporins, and carbapenems except in well-justified exceptional cases 2

References

Guideline

guideline for the management of acute sore throat.

Clinical Microbiology and Infection, 2012

Research

Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.